Yuhong Xu
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 21
- Rehabilitation top 2%
- Pharmaceutical Science top 2%
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 9
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 36
- Advanced biosensing and bioanalysis techniques 18
- Glycosylation and Glycoproteins Research 10
-
- Monoclonal and Polyclonal Antibodies Research 18
-
- Immunotherapy and Immune Responses 16
-
- Microbial Inactivation Methods 12
- Journals
- SHILAP Revista de lepidopterología (2 papers)ACS Nano (1 paper)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yuhong Xu
145 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Biomaterials 1.0k
- Rehabilitation 271
- Pharmaceutical Science 192
- Biomedical Engineering 1.1k
- Molecular Biology 1.7k
Countries citing papers authored by Yuhong Xu
This map shows the geographic impact of Yuhong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhong Xu more than expected).
Fields of papers citing papers by Yuhong Xu
This network shows the impact of papers produced by Yuhong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhong Xu. The network helps show where Yuhong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuhong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 17 | |
| 13 | Overexpression of protein tyrosine phosphatase 1B impairs glucose-stimulated insulin secretion in INS-1 cells. | 2016 | 6 |
| 14 | 2011 | 28 | |
| 15 | 2010 | 20 | |
| 16 | 2010 | 50 | |
| 17 | PRIMARY EVALUATION OF PEPTIDE LIGAND FUNCTIONALIZED MULTIWALLED CARBON NANOTUBES AS TUMOR TARGETING CELLS CARRIER | 2009 | 1 |
| 18 | 2007 | 6 | |
| 19 | 2006 | 23 | |
| 20 | 2005 | 7 |
About Yuhong Xu
Yuhong Xu is a scholar working on Biomaterials, Biotechnology and Pharmaceutical Science, having authored 154 papers that have together received 3.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (36 papers), Nanoparticle-Based Drug Delivery (21 papers), Advanced biosensing and bioanalysis techniques (18 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Immunotherapy and Immune Responses (16 papers), Microbial Inactivation Methods (12 papers), Glycosylation and Glycoproteins Research (10 papers) and Nanoplatforms for cancer theranostics (9 papers). The work is most often cited by research in Biomaterials (1.0k citations), Rehabilitation (271 citations) and Pharmaceutical Science (192 citations). Yuhong Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jinliang Peng, Jiang Chang, Jianren Gu, Ye Sun, Haiyan Li, Xiaohui Wei, Zonghai Li, Ruijiao Zhao, Ming Yao and Xianghua Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.